New heart mapping tech aims to zap stubborn AFib more safely

NCT ID NCT06529978

Recruiting now Disease control Sponsor: CoreMap Inc. Source: ClinicalTrials.gov ↗

First seen Mar 24, 2026 · Last updated May 22, 2026 · Updated 5 times

Summary

This study tests a new mapping system (CoreMap) that helps doctors find and treat the source of persistent atrial fibrillation (AFib) during a standard ablation procedure. About 245 adults with persistent AFib will take part. The main goals are to check safety and see if the system helps keep the heart in normal rhythm for 12 months after treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

NCH Downtown Baker Hospital
ENROLLING_BY_INVITATION

Naples, Florida, 34102, United States
Na Homolce Hospital
RECRUITING

Praha Klanovice, Czechia
University of Vermont Medical Center
ENROLLING_BY_INVITATION

Burlington, Vermont, 05401, United States

Conditions

Explore the condition pages connected to this study.

PERSISTENT ATRIAL FIBRILLATION